1. Home
  2. GLAD vs CLPT Comparison

GLAD vs CLPT Comparison

Compare GLAD & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

SELL

Current Price

$18.61

Market Cap

430.6M

Sector

Finance

ML Signal

SELL

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

SELL

Current Price

$10.67

Market Cap

467.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GLAD
CLPT
Founded
2001
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.6M
467.9M
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
GLAD
CLPT
Price
$18.61
$10.67
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$22.00
★ $23.50
AVG Volume (30 Days)
167.1K
★ 598.7K
Earning Date
11-17-2026
10-28-2026
Dividend Yield
★ 9.60%
N/A
EPS Growth
★ 91.82
N/A
EPS
★ 1.00
N/A
Revenue
N/A
★ $36,971,000.00
Revenue This Year
$12.97
$32.54
Revenue Next Year
$9.43
$15.41
P/E Ratio
$18.72
★ N/A
Revenue Growth
N/A
★ 17.78
52 Week Low
$16.54
$8.27
52 Week High
$21.73
$24.73

Technical Indicators

Market Signals
Indicator
GLAD
CLPT
Relative Strength Index (RSI) 46.30 49.08
Support Level $18.39 $8.61
Resistance Level $19.59 $11.90
Average True Range (ATR) 0.37 0.50
MACD -0.00 0.20
Stochastic Oscillator 43.53 97.28

Price Performance

Historical Comparison
GLAD
CLPT

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Share on Social Networks: